504345 — Oasis Nutraceuticals Income Statement
0.000.00%
Last trade - 00:00
HealthcareMicro Cap
2014 March 31st | 2015 March 31st | 2016 March 31st | 2017 March 31st | 2018 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 1.1 | 58.2 | 47.5 |
Cost of Revenue | |||||
Gross Profit | — | — | 0.001 | -1.65 | -2.5 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5.12 | 6.55 | 1.59 | 61.7 | 50.8 |
Operating Profit | -5.12 | -6.55 | -0.488 | -3.5 | -3.38 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 4.87 | 1.65 | 4.93 | 1.18 | 1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2.97 | -0.675 | 3.73 | 0.816 | 0.743 |
Net Income Before Extraordinary Items | |||||
Net Income | 2.97 | -0.675 | 3.73 | 0.816 | 0.743 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 2.97 | -0.675 | 3.73 | 0.816 | 0.743 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.029 | -0.007 | 0.037 | 0.008 | 0.007 |
Dividends per Share |